APA (7th ed.) Citation

Tang, Y., Liu, X., Ye, W., Wang, X., Wei, X., Du, Y., . . . Gong, Y. (2025). METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis. Cancer Medicine, 14(7), . https://doi.org/10.1002/cam4.70771

Chicago Style (17th ed.) Citation

Tang, Yuqian, Xiaoyan Liu, Wu Ye, Xiaojia Wang, Xiaoyu Wei, Yiwen Du, Ying Zhang, and Yuping Gong. "METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis." Cancer Medicine 14, no. 7 (2025). https://doi.org/10.1002/cam4.70771.

MLA (9th ed.) Citation

Tang, Yuqian, et al. "METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the PGC‐1α–MAPK Pathway and PGC‐1α–Antioxidant System Axis." Cancer Medicine, vol. 14, no. 7, 2025, https://doi.org/10.1002/cam4.70771.